What Is a Tirzepatide Titration Schedule?
A tirzepatide titration schedule is the step-by-step plan for raising your weekly dose of tirzepatide, starting at 2.5 mg and increasing by 2.5 mg no sooner than every 4 weeks. Tirzepatide is the active ingredient in Zepbound, approved for weight management and obstructive sleep apnea, and Mounjaro, approved for type 2 diabetes. Both FDA labels use the same starting dose and step-up pattern.
The slow start lowers the risk of digestive side effects. The 2.5 mg dose is for starting only, not for long-term use.
Tirzepatide Titration Schedule at a Glance
| Brand-name medicines | Zepbound (weight management, sleep apnea) and Mounjaro (type 2 diabetes) |
|---|---|
| How tirzepatide works | Mimics two gut hormones, GIP and GLP-1, to act on appetite areas of the brain, help the pancreas release insulin and slow stomach emptying. |
| How it's given | A once-weekly injection under the skin of the abdomen, thigh or upper arm (the label says another person should give upper-arm injections) |
| Starting dose | 2.5 mg once a week for 4 weeks |
| Dose increases | 2.5 mg at a time, after at least 4 weeks on the current dose |
| Maintenance dose | Weight management: 5, 10 or 15 mg. Sleep apnea: 10 or 15 mg. Maximum: 15 mg (Mounjaro: 10 mg for children 10 and older with type 2 diabetes). |
| Common side effects | Nausea, diarrhea, vomiting, constipation, abdominal pain and indigestion |
| FDA status | Zepbound and Mounjaro are FDA-approved. Compounded tirzepatide is not. |
The Standard Tirzepatide Dosing Timeline
The standard tirzepatide titration schedule moves up one dose level at a time, with at least 4 weeks at each level. At the fastest pace, it looks like this:
| Weeks (earliest) | Weekly dose | Zepbound maintenance option? |
|---|---|---|
| 1 to 4 | 2.5 mg | No. Starting dose only. |
| 5 to 8 | 5 mg | Yes, for weight management |
| 9 to 12 | 7.5 mg | No. Step-up dose. |
| 13 to 16 | 10 mg | Yes, for weight management or sleep apnea |
| 17 to 20 | 12.5 mg | No. Step-up dose. |
| 21 onward | 15 mg | Yes. This is the maximum dose. |
Clinicians choose a maintenance dose based on your response and side effects. Four weeks is the minimum time on each dose, not a deadline. If you can't tolerate a maintenance dose, the Zepbound label advises considering a lower one.
How to Take Tirzepatide During Titration
Inject tirzepatide once a week, at any time of day, with or without meals, and rotate the injection site.
- Missed dose: take it within 4 days (96 hours). After that, skip it and take the next dose on your usual day.
- Birth control pills: the Zepbound label advises switching to a non-oral method, or adding a barrier method, for 4 weeks after starting and after each dose increase.
- Diet and activity: American Diabetes Association guidelines recommend pairing obesity medicines with nutrition, physical activity and behavioral therapy.
Side Effects During Tirzepatide Titration
Digestive side effects are the most common problem during tirzepatide titration. In two Zepbound weight-reduction trials, nausea affected 25% to 29% of people on tirzepatide versus 8% on placebo, and most nausea, vomiting and diarrhea occurred during dose escalation and eased over time. To limit symptoms, the American Diabetes Association suggests:
- Eat small, frequent meals.
- Avoid greasy or sugary foods and strong odors.
- Stay hydrated.
Warnings and Who Shouldn't Take Tirzepatide
Tirzepatide has a boxed warning because it caused thyroid C-cell tumors in rats; whether it does in people is unknown. Don't use it if you or a family member has had medullary thyroid carcinoma, if you have multiple endocrine neoplasia syndrome type 2 (MEN 2), or if you've had a serious allergic reaction to tirzepatide. The Zepbound label says it isn't recommended with severe gastroparesis and should be stopped once pregnancy is recognized.
Call your clinician promptly about severe stomach pain that won't go away (a possible sign of pancreatitis), dehydration from vomiting or diarrhea, or signs of an allergic reaction. Tell any surgeon or anesthesia team that you take tirzepatide.
Tirzepatide vs. Semaglutide Titration Schedule
The tirzepatide titration schedule starts at a higher milligram dose and takes longer to reach its top dose than the semaglutide (Wegovy) schedule, but both step up every 4 weeks.
| Tirzepatide (Zepbound) | Semaglutide (Wegovy) | |
|---|---|---|
| Starting dose | 2.5 mg weekly for 4 weeks | 0.25 mg weekly for 4 weeks |
| Next steps | 5, 7.5, 10, 12.5 and 15 mg | 0.5, 1, 1.7 and 2.4 mg |
| Earliest top dose | Week 21 (15 mg) | Week 17 (2.4 mg) |
| Maintenance dose | 5, 10 or 15 mg | 2.4 mg (recommended) or 1.7 mg |
| Missed dose | Take within 4 days | Take if the next dose is more than 2 days away |
In the 72-week SURMOUNT-5 trial in adults with obesity but without type 2 diabetes, participants took the highest dose of each drug they could tolerate. Average weight loss was 20.2% with tirzepatide and 13.7% with semaglutide.
Tirzepatide Titration at GENEVA
At GENEVA Primary Care & Med Spa in Alpharetta, GA, a provider evaluates your health history, current medicines and goals. Based on that evaluation, your provider recommends treatment at GENEVA or a referral to a specialist.
You can start with GENEVA's medical weight loss services or, if you have type 2 diabetes, chronic disease management. GENEVA serves patients from Alpharetta, Johns Creek, Milton, Roswell and Cumming.
Related Terms
- Tirzepatide injections
- Zepbound
- Mounjaro
- Dual GIP/GLP-1 agonist
- Semaglutide titration schedule
- Compounded tirzepatide
- Weight plateau
Tirzepatide Titration Schedule FAQs
How long does it take to titrate tirzepatide?
Titrating tirzepatide to the 15 mg maximum takes at least 20 weeks, so the earliest you can start 15 mg is week 21. Each dose is used for at least 4 weeks before the next 2.5 mg increase. You may not need to go that far, because 5 mg and 10 mg are also approved maintenance doses for weight management. In the Zepbound weight-loss trials, dose escalation lasted up to 20 weeks. Four weeks is a minimum, so your clinician may keep you on a dose longer if side effects are bothersome.
Can you increase your tirzepatide dose faster than every 4 weeks?
No. The FDA labels for Zepbound and Mounjaro call for at least 4 weeks on each dose before the next increase, to reduce digestive side effects. The FDA has received adverse event reports, some serious, possibly linked to compounded semaglutide or tirzepatide increased faster than the approved schedule or taken at higher doses, with symptoms such as nausea, vomiting and abdominal pain. Your clinician may go slower than every 4 weeks, but never adjust the dose yourself.
Do tirzepatide side effects get worse with each dose increase?
Tirzepatide's digestive side effects are most common during titration and usually ease over time. In Zepbound trials, nausea rates were similar across doses: 25% at 5 mg, 29% at 10 mg and 28% at 15 mg, versus 8% with placebo. Severe digestive side effects were less common: 1.7% at 5 mg, 2.5% at 10 mg and 3.1% at 15 mg, versus 1% with placebo. Call your clinician if vomiting or diarrhea leaves you dehydrated, which can harm the kidneys.
What happens if I miss a tirzepatide dose?
If you miss a tirzepatide dose, take it within 4 days (96 hours). If more than 4 days have passed, skip it and take your next dose on your usual day. Keep at least 3 days (72 hours) between doses. The tirzepatide labels don't cover restarting after several missed weeks; the Wegovy (semaglutide) label notes that restarting its escalation schedule after 2 or more missed doses may reduce digestive symptoms. If you've missed several doses, ask your clinician which dose to restart at.
Do you have to reach 15 mg of tirzepatide?
No, you don't have to reach 15 mg of tirzepatide. For weight management, the Zepbound label lists 5, 10 or 15 mg as maintenance doses; for sleep apnea, 10 or 15 mg. In the 72-week SURMOUNT-1 trial, average weight loss was 15.0% at 5 mg, 19.5% at 10 mg and 20.9% at 15 mg, versus 3.1% with placebo. If a dose causes side effects you can't tolerate, the label advises considering a lower maintenance dose.
What happens when you stop tirzepatide after titration?
You will probably regain some weight after stopping tirzepatide, as with other weight-management medicines. In a trial on the Zepbound label, people first lost an average of 20.9% over 36 weeks on tirzepatide. Those then switched to placebo saw their weight rise 14.0% over the next 52 weeks. Those who stayed on tirzepatide lost another 5.5%. NIDDK notes clinicians may advise staying on a weight medicine long term if it helps without serious side effects. Talk with your clinician before stopping.
Can a primary care provider manage tirzepatide titration?
Yes, a primary care provider can evaluate whether tirzepatide fits your health and guide the titration schedule, including checking for reasons not to use it. According to NIDDK, weight-management medicine may be considered for adults with a BMI of 30 or higher, or 27 or higher with a weight-related problem such as high blood pressure or type 2 diabetes. At GENEVA in Alpharetta, a provider reviews your history, medicines and goals, then recommends treatment at GENEVA or a referral to a specialist.